2016版美国甲状腺协会《甲状腺功能亢进症和其他原因所致甲状腺毒症诊治指南》解读：外科部分  

Interpretation for surgical section of 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis

作　　者：雷尚通[1] 葛军娜[1] Lei Shangtong;Ge Junna(General Surgery Department, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China)

机构地区：[1]南方医科大学南方医院普通外科,广州510515

出　　处：《中华核医学与分子影像杂志》2018年第5期316-319,共4页Chinese Journal of Nuclear Medicine and Molecular Imaging

摘　　要：2016年美国甲状腺协会（ATA）发表的《甲状腺功能亢进症和其他原因所致甲状腺毒症诊治指南》，对2011版指南进行了补充和改进。新版更加强调甲状腺毒症的病因鉴别，对抗甲状腺药物（ATD）、^131I和手术这3种治疗方法的适应证都作了修改，并且对需行紧急甲状腺手术术前准备的甲状腺功能亢进症（简称甲亢）患者也提出了新的治疗策略。新版指南还吸纳了更多亚洲地区的研究结果，为中国未来的指南修订提供了一定的参考价值。该文主要就新版指南中的甲亢外科诊治建议进行解读。The guidelines for the diagnosis and treatment of hyperthyroidism and other causes of thyrotoxicosis published by the American Thyroid Association （ATA） in 2016, complement and improve the 2011 edition guidelines. The new guidelines put more emphases on the differential diagnosis of thyrotoxicosis; indications of treatment methods including antithyroid drugs （ATD） , ^131I and surgery were revised; a new therapeutic strategy was also put forward for the hyperthyroidism patients being to undergo emergency thyroid surgery. More researches in Asia were included, which provided a certain value for the revision of Chinese guidelines. This article mainly interprets the suggestions for the surgical diagnosis and treatment of hyperthyroidism in 2016 ATA guidelines.

关 键 词：甲状腺毒症 甲状腺功能亢进症 实践指南 外科手术 美国 

分 类 号：R581[医药卫生—内分泌]